Activation of the glucokinase enzyme can improve carbohydrate metabolism in the liver (glycolysis/glycogenesis) and enhance the insulinotropic response in the pancreas, which may also suggest long-term beneficial effects in the prevention of diabetic neuropathy and retinopathy, as well as in a reduction in hepatic glucose production. The gene discussed is GCK; the disease is diabetic neuropathy.